Projecting The Long-Term Benefits of Venetoclax Combination Therapies for Patients with Newly Diagnosed Acute Myeloid Leukemia who are Ineligible for Intensive ChemoTherapy: An Assessment of Net Health Benefits

Author

Schuh A, Pratz K, Lachaine J, Suh HS, Xie J, Chai X, Xie J, Gu C, and Bui C

Journal

The International Society for Pharmacoeconomics and Outcomes Research 24th Annual European Congress

Remarks

Virtual Conference. November 30 – December 3, 2021.